Global Anticoagulant Injections Market Research Report 2023
According to QYResearch’s new survey, global Anticoagulant Injections market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anticoagulant Injections market research.
Key companies engaged in the Anticoagulant Injections industry include Sanofi, Genentech (Roche), Boehringer Ingelheim, Aspen, Pfizer, Hepalink, King-friend, CSBIO and Amphastar Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Anticoagulant Injections were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Anticoagulant Injections market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anticoagulant Injections market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Key companies engaged in the Anticoagulant Injections industry include Sanofi, Genentech (Roche), Boehringer Ingelheim, Aspen, Pfizer, Hepalink, King-friend, CSBIO and Amphastar Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Anticoagulant Injections were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Anticoagulant Injections market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anticoagulant Injections market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Sanofi
- Genentech (Roche)
- Boehringer Ingelheim
- Aspen
- Pfizer
- Hepalink
- King-friend
- CSBIO
- Amphastar Pharmaceuticals
- LMWH
- Unfractionated Heparin
- Fibrinolytics
- Other
- VTE
- ACS/MI
- AF
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulant Injections Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 LMWH
1.2.3 Unfractionated Heparin
1.2.4 Fibrinolytics
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anticoagulant Injections Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Anticoagulant Injections Market Perspective (2018-2029)
2.2 Anticoagulant Injections Growth Trends by Region
2.2.1 Global Anticoagulant Injections Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anticoagulant Injections Historic Market Size by Region (2018-2023)
2.2.3 Anticoagulant Injections Forecasted Market Size by Region (2024-2029)
2.3 Anticoagulant Injections Market Dynamics
2.3.1 Anticoagulant Injections Industry Trends
2.3.2 Anticoagulant Injections Market Drivers
2.3.3 Anticoagulant Injections Market Challenges
2.3.4 Anticoagulant Injections Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Anticoagulant Injections Players by Revenue
3.1.1 Global Top Anticoagulant Injections Players by Revenue (2018-2023)
3.1.2 Global Anticoagulant Injections Revenue Market Share by Players (2018-2023)
3.2 Global Anticoagulant Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticoagulant Injections Revenue
3.4 Global Anticoagulant Injections Market Concentration Ratio
3.4.1 Global Anticoagulant Injections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Injections Revenue in 2022
3.5 Anticoagulant Injections Key Players Head office and Area Served
3.6 Key Players Anticoagulant Injections Product Solution and Service
3.7 Date of Enter into Anticoagulant Injections Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ANTICOAGULANT INJECTIONS BREAKDOWN DATA BY TYPE
4.1 Global Anticoagulant Injections Historic Market Size by Type (2018-2023)
4.2 Global Anticoagulant Injections Forecasted Market Size by Type (2024-2029)
5 ANTICOAGULANT INJECTIONS BREAKDOWN DATA BY APPLICATION
5.1 Global Anticoagulant Injections Historic Market Size by Application (2018-2023)
5.2 Global Anticoagulant Injections Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Anticoagulant Injections Market Size (2018-2029)
6.2 North America Anticoagulant Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anticoagulant Injections Market Size by Country (2018-2023)
6.4 North America Anticoagulant Injections Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Anticoagulant Injections Market Size (2018-2029)
7.2 Europe Anticoagulant Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anticoagulant Injections Market Size by Country (2018-2023)
7.4 Europe Anticoagulant Injections Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Anticoagulant Injections Market Size (2018-2029)
8.2 Asia-Pacific Anticoagulant Injections Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anticoagulant Injections Market Size by Region (2018-2023)
8.4 Asia-Pacific Anticoagulant Injections Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Anticoagulant Injections Market Size (2018-2029)
9.2 Latin America Anticoagulant Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anticoagulant Injections Market Size by Country (2018-2023)
9.4 Latin America Anticoagulant Injections Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anticoagulant Injections Market Size (2018-2029)
10.2 Middle East & Africa Anticoagulant Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anticoagulant Injections Market Size by Country (2018-2023)
10.4 Middle East & Africa Anticoagulant Injections Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anticoagulant Injections Introduction
11.1.4 Sanofi Revenue in Anticoagulant Injections Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Detail
11.2.2 Genentech (Roche) Business Overview
11.2.3 Genentech (Roche) Anticoagulant Injections Introduction
11.2.4 Genentech (Roche) Revenue in Anticoagulant Injections Business (2018-2023)
11.2.5 Genentech (Roche) Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Anticoagulant Injections Introduction
11.3.4 Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Aspen
11.4.1 Aspen Company Detail
11.4.2 Aspen Business Overview
11.4.3 Aspen Anticoagulant Injections Introduction
11.4.4 Aspen Revenue in Anticoagulant Injections Business (2018-2023)
11.4.5 Aspen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Anticoagulant Injections Introduction
11.5.4 Pfizer Revenue in Anticoagulant Injections Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Hepalink
11.6.1 Hepalink Company Detail
11.6.2 Hepalink Business Overview
11.6.3 Hepalink Anticoagulant Injections Introduction
11.6.4 Hepalink Revenue in Anticoagulant Injections Business (2018-2023)
11.6.5 Hepalink Recent Development
11.7 King-friend
11.7.1 King-friend Company Detail
11.7.2 King-friend Business Overview
11.7.3 King-friend Anticoagulant Injections Introduction
11.7.4 King-friend Revenue in Anticoagulant Injections Business (2018-2023)
11.7.5 King-friend Recent Development
11.8 CSBIO
11.8.1 CSBIO Company Detail
11.8.2 CSBIO Business Overview
11.8.3 CSBIO Anticoagulant Injections Introduction
11.8.4 CSBIO Revenue in Anticoagulant Injections Business (2018-2023)
11.8.5 CSBIO Recent Development
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Detail
11.9.2 Amphastar Pharmaceuticals Business Overview
11.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Introduction
11.9.4 Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2018-2023)
11.9.5 Amphastar Pharmaceuticals Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulant Injections Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 LMWH
1.2.3 Unfractionated Heparin
1.2.4 Fibrinolytics
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anticoagulant Injections Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Anticoagulant Injections Market Perspective (2018-2029)
2.2 Anticoagulant Injections Growth Trends by Region
2.2.1 Global Anticoagulant Injections Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anticoagulant Injections Historic Market Size by Region (2018-2023)
2.2.3 Anticoagulant Injections Forecasted Market Size by Region (2024-2029)
2.3 Anticoagulant Injections Market Dynamics
2.3.1 Anticoagulant Injections Industry Trends
2.3.2 Anticoagulant Injections Market Drivers
2.3.3 Anticoagulant Injections Market Challenges
2.3.4 Anticoagulant Injections Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Anticoagulant Injections Players by Revenue
3.1.1 Global Top Anticoagulant Injections Players by Revenue (2018-2023)
3.1.2 Global Anticoagulant Injections Revenue Market Share by Players (2018-2023)
3.2 Global Anticoagulant Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticoagulant Injections Revenue
3.4 Global Anticoagulant Injections Market Concentration Ratio
3.4.1 Global Anticoagulant Injections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Injections Revenue in 2022
3.5 Anticoagulant Injections Key Players Head office and Area Served
3.6 Key Players Anticoagulant Injections Product Solution and Service
3.7 Date of Enter into Anticoagulant Injections Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ANTICOAGULANT INJECTIONS BREAKDOWN DATA BY TYPE
4.1 Global Anticoagulant Injections Historic Market Size by Type (2018-2023)
4.2 Global Anticoagulant Injections Forecasted Market Size by Type (2024-2029)
5 ANTICOAGULANT INJECTIONS BREAKDOWN DATA BY APPLICATION
5.1 Global Anticoagulant Injections Historic Market Size by Application (2018-2023)
5.2 Global Anticoagulant Injections Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Anticoagulant Injections Market Size (2018-2029)
6.2 North America Anticoagulant Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anticoagulant Injections Market Size by Country (2018-2023)
6.4 North America Anticoagulant Injections Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Anticoagulant Injections Market Size (2018-2029)
7.2 Europe Anticoagulant Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anticoagulant Injections Market Size by Country (2018-2023)
7.4 Europe Anticoagulant Injections Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Anticoagulant Injections Market Size (2018-2029)
8.2 Asia-Pacific Anticoagulant Injections Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anticoagulant Injections Market Size by Region (2018-2023)
8.4 Asia-Pacific Anticoagulant Injections Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Anticoagulant Injections Market Size (2018-2029)
9.2 Latin America Anticoagulant Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anticoagulant Injections Market Size by Country (2018-2023)
9.4 Latin America Anticoagulant Injections Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anticoagulant Injections Market Size (2018-2029)
10.2 Middle East & Africa Anticoagulant Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anticoagulant Injections Market Size by Country (2018-2023)
10.4 Middle East & Africa Anticoagulant Injections Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anticoagulant Injections Introduction
11.1.4 Sanofi Revenue in Anticoagulant Injections Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Detail
11.2.2 Genentech (Roche) Business Overview
11.2.3 Genentech (Roche) Anticoagulant Injections Introduction
11.2.4 Genentech (Roche) Revenue in Anticoagulant Injections Business (2018-2023)
11.2.5 Genentech (Roche) Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Anticoagulant Injections Introduction
11.3.4 Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Aspen
11.4.1 Aspen Company Detail
11.4.2 Aspen Business Overview
11.4.3 Aspen Anticoagulant Injections Introduction
11.4.4 Aspen Revenue in Anticoagulant Injections Business (2018-2023)
11.4.5 Aspen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Anticoagulant Injections Introduction
11.5.4 Pfizer Revenue in Anticoagulant Injections Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Hepalink
11.6.1 Hepalink Company Detail
11.6.2 Hepalink Business Overview
11.6.3 Hepalink Anticoagulant Injections Introduction
11.6.4 Hepalink Revenue in Anticoagulant Injections Business (2018-2023)
11.6.5 Hepalink Recent Development
11.7 King-friend
11.7.1 King-friend Company Detail
11.7.2 King-friend Business Overview
11.7.3 King-friend Anticoagulant Injections Introduction
11.7.4 King-friend Revenue in Anticoagulant Injections Business (2018-2023)
11.7.5 King-friend Recent Development
11.8 CSBIO
11.8.1 CSBIO Company Detail
11.8.2 CSBIO Business Overview
11.8.3 CSBIO Anticoagulant Injections Introduction
11.8.4 CSBIO Revenue in Anticoagulant Injections Business (2018-2023)
11.8.5 CSBIO Recent Development
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Detail
11.9.2 Amphastar Pharmaceuticals Business Overview
11.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Introduction
11.9.4 Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2018-2023)
11.9.5 Amphastar Pharmaceuticals Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Anticoagulant Injections Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of LMWH
Table 3. Key Players of Unfractionated Heparin
Table 4. Key Players of Fibrinolytics
Table 5. Key Players of Other
Table 6. Global Anticoagulant Injections Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Anticoagulant Injections Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Anticoagulant Injections Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Anticoagulant Injections Market Share by Region (2018-2023)
Table 10. Global Anticoagulant Injections Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Anticoagulant Injections Market Share by Region (2024-2029)
Table 12. Anticoagulant Injections Market Trends
Table 13. Anticoagulant Injections Market Drivers
Table 14. Anticoagulant Injections Market Challenges
Table 15. Anticoagulant Injections Market Restraints
Table 16. Global Anticoagulant Injections Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Anticoagulant Injections Market Share by Players (2018-2023)
Table 18. Global Top Anticoagulant Injections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2022)
Table 19. Ranking of Global Top Anticoagulant Injections Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Anticoagulant Injections Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anticoagulant Injections Product Solution and Service
Table 23. Date of Enter into Anticoagulant Injections Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anticoagulant Injections Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Anticoagulant Injections Revenue Market Share by Type (2018-2023)
Table 27. Global Anticoagulant Injections Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Anticoagulant Injections Revenue Market Share by Type (2024-2029)
Table 29. Global Anticoagulant Injections Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Anticoagulant Injections Revenue Market Share by Application (2018-2023)
Table 31. Global Anticoagulant Injections Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Anticoagulant Injections Revenue Market Share by Application (2024-2029)
Table 33. North America Anticoagulant Injections Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Anticoagulant Injections Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Anticoagulant Injections Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Anticoagulant Injections Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Anticoagulant Injections Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Anticoagulant Injections Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Anticoagulant Injections Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Anticoagulant Injections Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Anticoagulant Injections Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anticoagulant Injections Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Anticoagulant Injections Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 48. Sanofi Company Detail
Table 49. Sanofi Business Overview
Table 50. Sanofi Anticoagulant Injections Product
Table 51. Sanofi Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 52. Sanofi Recent Development
Table 53. Genentech (Roche) Company Detail
Table 54. Genentech (Roche) Business Overview
Table 55. Genentech (Roche) Anticoagulant Injections Product
Table 56. Genentech (Roche) Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 57. Genentech (Roche) Recent Development
Table 58. Boehringer Ingelheim Company Detail
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Anticoagulant Injections Product
Table 61. Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 62. Boehringer Ingelheim Recent Development
Table 63. Aspen Company Detail
Table 64. Aspen Business Overview
Table 65. Aspen Anticoagulant Injections Product
Table 66. Aspen Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 67. Aspen Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Anticoagulant Injections Product
Table 71. Pfizer Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Hepalink Company Detail
Table 74. Hepalink Business Overview
Table 75. Hepalink Anticoagulant Injections Product
Table 76. Hepalink Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 77. Hepalink Recent Development
Table 78. King-friend Company Detail
Table 79. King-friend Business Overview
Table 80. King-friend Anticoagulant Injections Product
Table 81. King-friend Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 82. King-friend Recent Development
Table 83. CSBIO Company Detail
Table 84. CSBIO Business Overview
Table 85. CSBIO Anticoagulant Injections Product
Table 86. CSBIO Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 87. CSBIO Recent Development
Table 88. Amphastar Pharmaceuticals Company Detail
Table 89. Amphastar Pharmaceuticals Business Overview
Table 90. Amphastar Pharmaceuticals Anticoagulant Injections Product
Table 91. Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 92. Amphastar Pharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 1. Global Anticoagulant Injections Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of LMWH
Table 3. Key Players of Unfractionated Heparin
Table 4. Key Players of Fibrinolytics
Table 5. Key Players of Other
Table 6. Global Anticoagulant Injections Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Anticoagulant Injections Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Anticoagulant Injections Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Anticoagulant Injections Market Share by Region (2018-2023)
Table 10. Global Anticoagulant Injections Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Anticoagulant Injections Market Share by Region (2024-2029)
Table 12. Anticoagulant Injections Market Trends
Table 13. Anticoagulant Injections Market Drivers
Table 14. Anticoagulant Injections Market Challenges
Table 15. Anticoagulant Injections Market Restraints
Table 16. Global Anticoagulant Injections Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Anticoagulant Injections Market Share by Players (2018-2023)
Table 18. Global Top Anticoagulant Injections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2022)
Table 19. Ranking of Global Top Anticoagulant Injections Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Anticoagulant Injections Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anticoagulant Injections Product Solution and Service
Table 23. Date of Enter into Anticoagulant Injections Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anticoagulant Injections Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Anticoagulant Injections Revenue Market Share by Type (2018-2023)
Table 27. Global Anticoagulant Injections Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Anticoagulant Injections Revenue Market Share by Type (2024-2029)
Table 29. Global Anticoagulant Injections Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Anticoagulant Injections Revenue Market Share by Application (2018-2023)
Table 31. Global Anticoagulant Injections Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Anticoagulant Injections Revenue Market Share by Application (2024-2029)
Table 33. North America Anticoagulant Injections Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Anticoagulant Injections Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Anticoagulant Injections Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Anticoagulant Injections Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Anticoagulant Injections Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Anticoagulant Injections Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Anticoagulant Injections Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Anticoagulant Injections Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Anticoagulant Injections Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anticoagulant Injections Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Anticoagulant Injections Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 48. Sanofi Company Detail
Table 49. Sanofi Business Overview
Table 50. Sanofi Anticoagulant Injections Product
Table 51. Sanofi Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 52. Sanofi Recent Development
Table 53. Genentech (Roche) Company Detail
Table 54. Genentech (Roche) Business Overview
Table 55. Genentech (Roche) Anticoagulant Injections Product
Table 56. Genentech (Roche) Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 57. Genentech (Roche) Recent Development
Table 58. Boehringer Ingelheim Company Detail
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Anticoagulant Injections Product
Table 61. Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 62. Boehringer Ingelheim Recent Development
Table 63. Aspen Company Detail
Table 64. Aspen Business Overview
Table 65. Aspen Anticoagulant Injections Product
Table 66. Aspen Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 67. Aspen Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Anticoagulant Injections Product
Table 71. Pfizer Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Hepalink Company Detail
Table 74. Hepalink Business Overview
Table 75. Hepalink Anticoagulant Injections Product
Table 76. Hepalink Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 77. Hepalink Recent Development
Table 78. King-friend Company Detail
Table 79. King-friend Business Overview
Table 80. King-friend Anticoagulant Injections Product
Table 81. King-friend Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 82. King-friend Recent Development
Table 83. CSBIO Company Detail
Table 84. CSBIO Business Overview
Table 85. CSBIO Anticoagulant Injections Product
Table 86. CSBIO Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 87. CSBIO Recent Development
Table 88. Amphastar Pharmaceuticals Company Detail
Table 89. Amphastar Pharmaceuticals Business Overview
Table 90. Amphastar Pharmaceuticals Anticoagulant Injections Product
Table 91. Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2018-2023) & (US$ Million)
Table 92. Amphastar Pharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Anticoagulant Injections Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Anticoagulant Injections Market Share by Type: 2022 VS 2029
Figure 3. LMWH Features
Figure 4. Unfractionated Heparin Features
Figure 5. Fibrinolytics Features
Figure 6. Other Features
Figure 7. Global Anticoagulant Injections Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Anticoagulant Injections Market Share by Application: 2022 VS 2029
Figure 9. VTE Case Studies
Figure 10. ACS/MI Case Studies
Figure 11. AF Case Studies
Figure 12. Other Case Studies
Figure 13. Anticoagulant Injections Report Years Considered
Figure 14. Global Anticoagulant Injections Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Anticoagulant Injections Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Anticoagulant Injections Market Share by Region: 2022 VS 2029
Figure 17. Global Anticoagulant Injections Market Share by Players in 2022
Figure 18. Global Top Anticoagulant Injections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Anticoagulant Injections Revenue in 2022
Figure 20. North America Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Anticoagulant Injections Market Share by Country (2018-2029)
Figure 22. United States Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Anticoagulant Injections Market Share by Country (2018-2029)
Figure 26. Germany Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Anticoagulant Injections Market Share by Region (2018-2029)
Figure 34. China Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Anticoagulant Injections Market Share by Country (2018-2029)
Figure 42. Mexico Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Anticoagulant Injections Market Share by Country (2018-2029)
Figure 46. Turkey Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Sanofi Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 49. Genentech (Roche) Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 51. Aspen Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 53. Hepalink Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 54. King-friend Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 55. CSBIO Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 56. Amphastar Pharmaceuticals Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Figure 1. Global Anticoagulant Injections Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Anticoagulant Injections Market Share by Type: 2022 VS 2029
Figure 3. LMWH Features
Figure 4. Unfractionated Heparin Features
Figure 5. Fibrinolytics Features
Figure 6. Other Features
Figure 7. Global Anticoagulant Injections Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Anticoagulant Injections Market Share by Application: 2022 VS 2029
Figure 9. VTE Case Studies
Figure 10. ACS/MI Case Studies
Figure 11. AF Case Studies
Figure 12. Other Case Studies
Figure 13. Anticoagulant Injections Report Years Considered
Figure 14. Global Anticoagulant Injections Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Anticoagulant Injections Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Anticoagulant Injections Market Share by Region: 2022 VS 2029
Figure 17. Global Anticoagulant Injections Market Share by Players in 2022
Figure 18. Global Top Anticoagulant Injections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Anticoagulant Injections Revenue in 2022
Figure 20. North America Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Anticoagulant Injections Market Share by Country (2018-2029)
Figure 22. United States Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Anticoagulant Injections Market Share by Country (2018-2029)
Figure 26. Germany Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Anticoagulant Injections Market Share by Region (2018-2029)
Figure 34. China Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Anticoagulant Injections Market Share by Country (2018-2029)
Figure 42. Mexico Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Anticoagulant Injections Market Share by Country (2018-2029)
Figure 46. Turkey Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Anticoagulant Injections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Sanofi Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 49. Genentech (Roche) Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 51. Aspen Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 53. Hepalink Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 54. King-friend Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 55. CSBIO Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 56. Amphastar Pharmaceuticals Revenue Growth Rate in Anticoagulant Injections Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
